Iridex (IRIX) Other financing activities (2011 - 2024)

Iridex (IRIX) posted quarterly Other financing activities of $4000.0 for Q3 2024, down 91.11% quarter-over-quarter from $45000.0 in Q4 2023.

Iridex (IRIX) Other financing activities (2011 - 2024) Analysis & Trends

Iridex's Other financing activities history runs 12 years deep, the most recent figure standing at $4000.0 for Q3 2024.

In Q3 2024, Other financing activities changed N/A year-over-year to $4000.0; the TTM figure through Jan 2026 stood at $4000.0 (changed 0.0% YoY), while the FY2024 annual figure was $4000.0, down 95.12% from the prior year.
Other financing activities for Q3 2024 stood at $4000.0, down from $45000.0 in the prior quarter.
The five-year high for Other financing activities was $45000.0 in Q4 2023, with the low at $4000.0 in Q3 2024.
The 4-year median for Other financing activities is $15500.0 (2021), against an average of $20666.7.
The sharpest annual moves came in 2022 and 2023: Other financing activities retreated 17.65% in 2022, then jumped 164.29% in 2023.
Iridex's Other financing activities stood at $17000.0 in 2021, then tumbled by 58.82% to $7000.0 in 2022, then jumped by 542.86% to $45000.0 in 2023, then sank by 91.11% to $4000.0 in 2024.
Business Quant data shows IRIX's Other financing activities at $4000.0 in Q3 2024, $45000.0 in Q4 2023, and $37000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Iridex	13.27 Mn	8.59 Mn	4.30 Mn

Download Data